Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | OWEN KATEY EINTERZ | Aug 26, 2026 | Sell | $249.99K | 9,615 |
| Director | HERSHBERG ROBERT | Aug 18, 2026 | Sell | $365.85K | 15,000 |
| Director | HERSHBERG ROBERT | Aug 18, 2026 | Sell | $382.36K | 15,664 |
| CEO | ROBINS CHAD M | Aug 18, 2026 | Sell | $6.82M | 278,472 |
| CEO | ROBINS CHAD M | Aug 18, 2026 | Sell | $5.13K | 204 |
| Director | NEUPERT PETER M | Aug 17, 2026 | Sell | $378.45K | 15,000 |
| CEO | ROBINS CHAD M | Aug 17, 2026 | Sell | $8M | 318,799 |
| Director | NEUPERT PETER M | Aug 17, 2026 | Sell | $1M | 40,000 |
| CEO | ROBINS CHAD M | Aug 17, 2026 | Sell | $64.56K | 2,525 |
| Director | NEUPERT PETER M | Aug 17, 2026 | Sell | $1.75M | 69,690 |
| Chief Commercial Officer, MRD | BOBULSKY SUSAN | Aug 10, 2026 | Sell | $75K | 3,000 |
| Chief Commercial Officer, MRD | BOBULSKY SUSAN | Jul 30, 2026 | Sell | $31.18K | 1,299 |
| Chief Scientific Officer | ROBINS HARLAN S | Jul 21, 2026 | Sell | $6.05M | 278,698 |
| Chief Scientific Officer | ROBINS HARLAN S | Jul 21, 2026 | Sell | $4.73M | 213,702 |
| Chief Commercial Officer, MRD | BOBULSKY SUSAN | Jul 16, 2026 | Sell | $115K | 5,000 |
| Chief People Officer | LO FRANCIS | Jul 15, 2026 | Sell | $2.39M | 105,762 |
| Chief Scientific Officer | ROBINS HARLAN S | Jul 2, 2026 | Sell | $5.2M | 239,351 |
| Chief Scientific Officer | ROBINS HARLAN S | Jul 2, 2026 | Sell | $3.3M | 146,889 |
| Chief People Officer | LO FRANCIS | Jul 2, 2026 | Sell | $1.01M | 44,838 |
| Chief Commercial Officer, MRD | BOBULSKY SUSAN | Jul 1, 2026 | Sell | $10.71K | 487 |
| Chief People Officer | LO FRANCIS | Jul 1, 2026 | Sell | $193.92K | 8,743 |
| Chief People Officer | LO FRANCIS | Jul 1, 2026 | Sell | $950.87K | 42,261 |
| Chief Commercial Ofc Imm Med | BENZENO SHARON | Jun 29, 2026 | Sell | $3.27M | 154,768 |
| Chief Commercial Ofc Imm Med | BENZENO SHARON | Jun 26, 2026 | Sell | $231.71K | 11,034 |
| Chief Commercial Officer, MRD | BOBULSKY SUSAN | Jun 25, 2026 | Sell | $102.5K | 5,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
